Survival Curve from Scientific Research

KM curve showing that patients with radiographic treatment response of SD at the week 6 tumor assessment can be risk stratified using the final C3D1 OS ctDNA model in the hold-back test data, identifying SD/ctDNA high-risk patients (mPD, solid curve) and SD/ctDNA low-intermediate risk patients (mSD + mResp, dashed curve). A univariable Cox proportional-hazards model was used to estimate HR and log-rank test to report P value. The exact P value indicated by ‘ P < 0.001’ is 8.8076 x 10 -7.

DOI